2016
DOI: 10.3109/13816810.2015.1130152
|View full text |Cite
|
Sign up to set email alerts
|

Argus II retinal prosthesis system: An update

Abstract: This review focuses on a description of the Argus II retinal prosthesis system (Argus II; Second Sight Medical Products, Sylmar, CA) that was approved for humanitarian use by the FDA in 2013 in patients with retinitis pigmentosa with bare or no light perception vision. The article describes the components of Argus II, the studies on the implant, and future directions.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
26
0
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(27 citation statements)
references
References 41 publications
0
26
0
1
Order By: Relevance
“…The first retinal prosthesis to enter clinical trials was a 5000-electrode microphotodiode chip (Artificial Silicon Retina [ASR], subretinal approach; Optobionics, Glen Ellyn, Ill, 2000, see [57]), and it produced successful results. At present, two devices have been approved as commercial products with clinical trials: the subretinal visual implants Alpha IMS (Retina Implant AG, Reutlingen, Germany, see [8,9]), which induce excitation of the internal plexiform layer, and the Argus II implants (Second Sight, Sylmar, CA, see [1012]), which induce excitation of the ganglion cell axons with an epiretinal implant, requiring simpler and less invasive surgery.…”
Section: Introductionmentioning
confidence: 99%
“…The first retinal prosthesis to enter clinical trials was a 5000-electrode microphotodiode chip (Artificial Silicon Retina [ASR], subretinal approach; Optobionics, Glen Ellyn, Ill, 2000, see [57]), and it produced successful results. At present, two devices have been approved as commercial products with clinical trials: the subretinal visual implants Alpha IMS (Retina Implant AG, Reutlingen, Germany, see [8,9]), which induce excitation of the internal plexiform layer, and the Argus II implants (Second Sight, Sylmar, CA, see [1012]), which induce excitation of the ganglion cell axons with an epiretinal implant, requiring simpler and less invasive surgery.…”
Section: Introductionmentioning
confidence: 99%
“…The Argus II retinal prosthesis system is marked for "European Conformity" (Conformité Européene -CE) and has been available in the European Economic Area since 2011. In addition, the system is accepted as a humanitarian device with authorization by the Food and Drug Administration of the United States [6]. The Argus II RPS has been implanted in patients from various countries who have totally lost their central vision [5,6].…”
Section: Introductionmentioning
confidence: 99%
“…The Argus II project is a well-known RPS that provides electrical stimulation of the retina to induce visual perception in blind individuals [6]. The block diagram of the system is illustrated in Figure 1, which appears courtesy of Prof Dr Mark S Humayun and Second Sight Medical Products.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Regarding vision assistance, there is a prosthetic system for the most severe cases with none or almost no light perception. The Argus II device provides a sort of artificial vision by sidestepping the photoreceptors and supplying the electric stimuli directly to the residual retina (Rachitskaya and Yuan 2016). This retinal prosthesis is composed of a set of glasses, an external video processing unit, and an on-globe surface implant coil that connects through cables to the last component, an electrode in the retina.…”
Section: Prosthetic Systemsmentioning
confidence: 99%